Concepedia

Kaoru Kondo

KK

38

Publications

7.3K

Citations

23

H-Index

1964

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Bristol-Myers Squibb (United States)

Kanazawa University

Centrum Onkologii

Johannes Gutenberg University Mainz

Kaoru Kondo is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, chemistry, and organic chemistry.

ORCID

Top concepts

Publications per year

1964–2023

38

Publications

38

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian, Kohei Shitara, Markus Moehler et al. · The Lancet · 2021 · 2.7K citations · Full text

, , +7

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly, Jaffer A. Ajani, Thomas Zander et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Yuichiro� Doki, Jaffer A. Ajani, Ken Kato et al. · UCL Discovery (University College London) · 2022 · 532 citations · Full text

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

Kohei Shitara, Jaffer A. Ajani, Markus Moehler et al. · Nature · 2022 · 415 citations · Full text

Stereoselective synthesis of alkenes and alkenyl sulfides from alkenyl halides using palladium and ruthenium catalysts

Shun‐Ichi Murahashi, Masaaki Yamamura, Kenichi Yanagisawa et al. · The Journal of Organic Chemistry · 1979 · 328 citations

, , +12

Rows per page

1–5 of 38